Condensed Consolidated Statements of Operations (unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Operating expenses:
Research and development expenses	$ 565,962	$ 1,361,683
General and administrative expenses	8,659,692	2,700,742
Total operating expenses	9,225,654	4,062,425
Loss from operations	(9,225,654)	(4,062,425)
Other (expenses) income:
Interest expense	(66,202)	(8,987)
Interest income	228	1,873
Other expense	(653)	(1,114)
Total other expenses	(66,627)	(8,228)
Loss before income tax benefit	(9,292,281)	(4,070,653)
Income tax benefit	14,859,887
Net income (loss)	5,567,606	(4,070,653)
Preferred stock dividends	(66,144)	(87,431)
Net income (loss) applicable to common shareholders	$ 5,501,462	$ (4,158,084)
Basic weighted average shares outstanding	1,761,953	114,033
Diluted weighted average shares outstanding	14,511,461	114,033
Income (loss) per share - basic	$ 3.12	$ (36.46)
Income (loss) per share - diluted	$ 0.38	$ (36.46)